Registry Following Adults With Diabetes, Blood Pressure, Heart or Kidney Disease
Records how adults with type 2 diabetes, hypertension, heart failure or kidney disease are managed.
Plain-language title generated from the registry record
Registry title: iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Key facts
- Where
- Nairobi, KenyaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for adults with type 2 diabetes, high blood pressure, heart failure and/or chronic kidney disease. It collects real-world data on their care.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Type 2 diabetes, hypertension, heart failure and/or chronic kidney disease
Main reasons for not taking part
- A life-threatening illness with life expectancy below 1 year
- Taking part in an interventional trial that requires informed consent
Read by machine on 9 November 2026.
Where in Kenya
- NairobiNairobi, KenyaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AstraZeneca
- Trial code
- NCT03549754
- Record updated
- 9 September 2026
- Original description
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseasesRead full original descriptionShow less
Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Inclusion: Being 18 years or older; Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease; Providing written informed consent to participate in the registry.
Exclusion: Having a life-threatening co-morbidity with life expectancy below 1 year; Participating in an interventional trial requiring informed consent.